Clinical Trials List
2022-04-01 - 2027-03-26
Phase III
Recruiting8
ICD-10I82.0
Budd-Chiari syndrome
ICD-9453.0
Budd-Chiari syndrome
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 楊舜如 Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳新炫 Division of Hematology & Oncology
- 鄭小湘 Division of Hematology & Oncology
- 陳建廷 Division of Hematology & Oncology
- 褚乃銘 Division of Hematology & Oncology
- 黃敬元 Division of Hematology & Oncology
- 譚傳德 Division of Hematology & Oncology
- 陳鵬宇 Division of Hematology & Oncology
- 鍾奇峰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jian-Ri Li
- Chuan-Shu Chen
- YU-HSUAN SHIH
- 滕傑林 Division of Hematology & Oncology
- HSIN-CHEN LIN
- Cheng-Kuang Yang
- ZHENG-WEI ZHOU
- Tsung -Chih Chen
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Huai-Hsuan Huang Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- Chien-Chin Lin Division of General Internal Medicine
- Chieh-Lung Cheng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 賴學緯 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
37 participants
-
Global
1655 participants
